Literature DB >> 11077897

Age, sex and practice variations in the use of statins in general practice in England and Wales.

A Majeed1, K Moser, R Maxwell.   

Abstract

BACKGROUND: Statins are highly effective in reducing the risk of sudden cardiac death and other acute coronary events in patients with pre-existing ischaemic heart disease or with raised blood cholesterol levels. However, relatively little is known about how statins are used in primary care. The objectives of this study were to investigate age, sex and inter-practice variations in the prescribing of statins.
METHODS: This was an observational study of statin prescribing rates in 288 general practices in England and Wales that contributed data to the General Practice Research Database in 1996.
RESULTS: In 1996, 0.7 per cent of men and 0.5 per cent of women received a prescription for a statin. In the subgroup of patients with a general practitioner (GP) diagnosis of ischaemic heart disease, 13.3 per cent of men and 8.2 per cent of women received a prescription for a statin in 1996. Below the age of 65 years, men with ischaemic heart disease were more likely to be prescribed a statin than were women. Patients aged 75 years and over with ischaemic heart disease were unlikely to be prescribed a statin irrespective of their sex. The percentage of patients prescribed statins in individual practices varied from 0.1 to 2.3 per cent in men and from 0 to 2.3 per cent in women. The recorded prevalence of ischaemic heart disease explained only 12 per cent of this variation in men and 7 per cent in women.
CONCLUSIONS: There are large age, sex and inter-practice variations in the use of statins in primary care, which are poorly explained by measures of health need. Developing and implementing clinical guidelines to accompany the introduction of new drugs for the management of common chronic disorders should be seen as a priority for GPs, primary care groups and the National Institute of Clinical Excellence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077897     DOI: 10.1093/pubmed/22.3.275

Source DB:  PubMed          Journal:  J Public Health Med        ISSN: 0957-4832


  18 in total

1.  Patients with acute coronary syndrome should start a statin while still in hospital.

Authors:  C G Isles
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

2.  Variations and increase in use of statins across Europe: data from administrative databases.

Authors:  Tom Walley; Pietro Folino-Gallo; Ulrich Schwabe; Eric van Ganse
Journal:  BMJ       Date:  2004-02-14

3.  Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study.

Authors:  Reimar W Thomsen; Søren P Johnsen; Anne V Olesen; Jens T Mortensen; Henrik Bøggild; Jørn Olsen; Henrik T Sørensen
Journal:  Br J Clin Pharmacol       Date:  2005-11       Impact factor: 4.335

4.  Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics.

Authors:  Chen-Chang Yang; Susan S Jick; Marcia A Testa
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

5.  The impact of statins on health services utilization and mortality in older adults discharged from hospital with ischemic heart disease: a cohort study.

Authors:  Charmaine A Cooke; Susan A Kirkland; Ingrid S Sketris; Jafna Cox
Journal:  BMC Health Serv Res       Date:  2009-11-04       Impact factor: 2.655

6.  Are GP practice prescribing rates for coronary heart disease drugs equitable? A cross sectional analysis in four primary care trusts in England.

Authors:  P R Ward; P R Noyce; A S St Leger
Journal:  J Epidemiol Community Health       Date:  2004-02       Impact factor: 3.710

Review 7.  [Recommendations for statin therapy in the elderly].

Authors:  S Döser; W März; M-F Reinecke; P Ringleb; A Schultz; P Schwandt; H J Becker; G Bönner; M Buerke; H C Diener; H Gohlke; U Keil; E B Ringelstein; A Steinmetz; R Gladisch; M Wehling
Journal:  Internist (Berl)       Date:  2004-08-03       Impact factor: 0.743

8.  Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.

Authors:  Chen-Chang Yang; Susan S Jick; Marcia A Testa
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

9.  Use of statins in the secondary prevention of coronary heart disease: is treatment equitable?

Authors:  F D A Reid; D G Cook; P H Whincup
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

Review 10.  Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women. A conceptual model.

Authors:  Catherine Kim; Timothy P Hofer; Eve A Kerr
Journal:  J Gen Intern Med       Date:  2003-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.